1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Clinical Trials Supplies Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Clinical Trials Supplies Market – Key Market Dynamics
5.4 Impact of Drivers and Restraints
6. North America Clinical Trials Supplies Market Regional Analysis
6.1 North America Clinical Trials Supplies Market Overview
6.2 North America Clinical Trials Supplies Market Revenue 2017-2027 (US$ Million)
6.3 North America Clinical Trials Supplies Market Forecast Analysis
7. North America Clinical Trials Supplies Market Analysis – by Product & Service
7.1 Manufacturing
- 7.1.1 Overview
- 7.1.2 Manufacturing: North America Clinical Trials Supplies Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Packaging & Labelling
- 7.2.1 Overview
- 7.2.2 Packaging & Labelling: North America Clinical Trials Supplies Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Logistics & Distribution
- 7.3.1 Overview
- 7.3.2 Logistics & Distribution: North America Clinical Trials Supplies Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Clinical Trials Supplies Market Analysis – by Stage
8.1 Phase I
- 8.1.1 Overview
- 8.1.2 Phase I: North America Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Phase II
- 8.2.1 Overview
- 8.2.2 Phase II: North America Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Phase III
- 8.3.1 Overview
- 8.3.2 Phase III: North America Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Bioequivalence Studies
- 8.4.1 Overview
- 8.4.2 Bioequivalence Studies: North America Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)
9. North America Clinical Trials Supplies Market Analysis – by Drug Type
9.1 Small-Molecule Drugs
- 9.1.1 Overview
- 9.1.2 Bioequivalence Studies: North America Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Biologic Drugs
- 9.2.1 Overview
- 9.2.2 Bioequivalence Studies: North America Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)
10. North America Clinical Trials Supplies Market – North America Analysis
10.1 North America
- 10.1.1 North America Clinical Trials Supplies Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.1.1.1 North America Clinical Trials Supplies Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.1.1 US: North America Clinical Trials Supplies Market Breakdown, by Product & Service
- 10.1.1.1.2 US: North America Clinical Trials Supplies Market Breakdown, by Stage
- 10.1.1.1.3 US: North America Clinical Trials Supplies Market Breakdown, by Drug Type
- 10.1.1.2 Canada:
North America Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.2.1 Canada: North America Clinical Trials Supplies Market Breakdown, by Product & Service
- 10.1.1.2.2 Canada: North America Clinical Trials Supplies Market Breakdown, by Stage
- 10.1.1.2.3 Canada: North America Clinical Trials Supplies Market Breakdown, by Drug Type
- 10.1.1.3 Mexico :
North America Clinical Trials Supplies Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.3.1 Mexico : North America Clinical Trials Supplies Market Breakdown, by Product & Service
- 10.1.1.3.2 Mexico : North America Clinical Trials Supplies Market Breakdown, by Stage
- 10.1.1.3.3 Mexico : North America Clinical Trials Supplies Market Breakdown, by Drug Type
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Clinical Trials Supplies Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 UDG Healthcare plc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Catalent Inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 pci Pharma Services
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Almac Group
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 PAREXEL INTERNATIONAL CORPORATION
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Biocair
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Owens & Minor Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Rubicon Research Pvt. Ltd
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 CLINICAL SUPPLIES MANAGEMENT HOLDINGS, INC.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For North America Clinical Trials Supplies Market
